| | | | | - | - | | | |   
                     
| | - | | - | ' '   |     /

  -
  ? 
  ,  
  , ,
  , ,
    ......
   
 
  -.
 
  ...
  
    - 
 
   
  .   
  
  • -
  • BMI
  • :
       
     
    ,

    :

    :
    - -, , . , .

    ' - , , , -; , , -

     

    -, , .

    - 1987, , .

    , , : lovastatin   - Mavacor, simvastatin - Zocor, pravastatin - Pravachol, fluvatatin - Lescol, atorvastatin - Lipitor - rosuvastatin - Crestor. 2010, Pitavastatin Livalo.

     

    1, . - D, , .

    . . , , .

     

    HMG-CoA reductase , .

    , -LDL "". HMG-CoA reductase, . -LDL.

    "". Zocor 5 80 - LDL - 26% 47%, ; - Pravachol 10 80 LDL - 22% 37%, ; Mevacor, 10 40 , - LDL - 10 40%;  Lipitor 10 80 LDL - 39% 60%; Lescol, 20 80 LDL - 22 35%; Crestor 5 - LDL - 45% 63%, . LDL 20 Lipitor, 40 80 Zocor, 5 Crestor.

     

    2003 Nissan. , pitavastatin , 1-4 LDL , 32-43%.

     

    -LDL "", , , -LDL, , - .

    -LDL, . -20 , , , (stents), -.

     

    , LDL, . , , , .

    , , , .

    , , LDL , " ", - - . , , .

     

    , . 2009 -Circulation, Veterans Administration , , -, - 8 , .

     

    :

    , . - -90, 40 LDL, -, , -20%.

    , . , . , , , .

     

      , , -5% , 20 . , .

    , . 800 1,000 D , .  

     

    , (rhabdomyolysis), .

    , , , (glomeruli) , "" .

    50,000 , .  

    , "   CYP3A4, , . Gerald Gau -Mayo Clinic, , , .

     

    , , .   , .

    , , 6 .

    -3 . , , .

     

    ?

    , , HMG-CoA reductase   .

    -Zocor, -Mevacor, -Lescol .

    Lipitor, Crestor -Pravachol , .

     

    , , , . , .

    . , - simvastatin -atorvastatin, , -. , , .

     

    . 2008 -20 , .

    ", , . 500 2,000 , (lovastatin , pravastatin -simvastatin) 100 .  

    Pfizer atorvastatin וּכּ Lipitor, : " -simvastatin, Zocor!" Pfizer , " ". Zocor Merck , .

     

    ?

    -80, - . , , -, , , , .

    JUPITER 2008, LDL , CRP , , . !

     

    , , -


    12/12/2010

     
       


    , , " , "
    , " " .

    - .

    / , , , / / . .
    / , , , / , / . .

    ,
    / " .




    | |
    | | | | | | |
    | | | |
    | | | |